Author + information
- Received May 4, 2020
- Revision received May 14, 2020
- Accepted May 15, 2020
- Published online July 15, 2020.
- Iqbal El-Assaad, MDa,∗∗ (, )
- M. Indriati Hood-Pishchany, MD, PhDb,∗,
- John Kheir, MDa,
- Kshitij Mistry, MDa,
- Avika Dixit, MBBS, MPHa,
- Olha Halyabar, MDc,
- Douglas Y. Mah, MDa,
- Colin Meyer-Macaulay, MDa,† and
- Henry Cheng, MDa,†
- aDepartment of Cardiology, Boston Children’s Hospital, Boston, Massachusetts
- bDivision of Infectious Disease, Department of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts
- cRheumatology Program, Division of Immunology, Boston Children’s Hospital, Boston, Massachusetts
- ↵∗Address for correspondence:
Dr. Iqbal El-Assaad, Department of Cardiology, Boston Children’s Hospital, Boston, Massachusetts 02215.
A young child presented with severe ventricular dysfunction and troponin leak in the setting of coronavirus disease-2019. He developed intermittent, self-resolving, and hemodynamically insignificant episodes of complete heart block that were diagnosed on telemetry and managed conservatively. This report is the first description of coronavirus disease-2019–induced transient complete heart block in a child. (Level of Difficulty: Intermediate.)
↵∗ Drs. El-Assaad and Hood-Pishchany contributed equally to this paper.
↵† Drs. Meyer-Macaulay and Cheng are co-senior authors.
Dr. Hood Pishchany is supported by a Physician Scientist Fellowship from the Doris Duke Charitable Foundation (2019129) and a Child Health Research Career Development Award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12 HD052896 13). Dr. Dixit is supported by a Boston Children’s Hospital OFD/BTREC/CTREC Faculty Career Development Fellowship and the Bushrod H. Campbell and Adah F. Hall Charity Fund/Charles A. King Trust Postdoctoral Fellowship. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Case Reports author instructions page.
- Received May 4, 2020.
- Revision received May 14, 2020.
- Accepted May 15, 2020.